Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Colcrys Promo Eats Pavement As FDA Objects To Ad Of Motorcyclist Holding Teacup

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA asks Mutual to stop using a pharmacy sell sheet that describes the gout drug as “gentle.” It also cites a video for failing to convey serious risk information and suggesting the drug is as tolerable as a placebo and superior to NSAIDs.

Advertisement

Related Content

With URL, Takeda Looks To Become U.S. Gout Therapy Provider Of Choice
With URL, Takeda Looks To Become U.S. Gout Therapy Provider Of Choice
Hill Democrats Continue Inquiries Into High Prices For New Versions Of Old Drugs; Avanir's Nuedexta And URL Pharma's Colcrys Targeted

Topics

Advertisement
UsernamePublicRestriction

Register

PS073251

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel